Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia | 3 | 2024 | 54 | 2.150 |
Why?
|
| Pneumonia, Bacterial | 3 | 2021 | 22 | 1.550 |
Why?
|
| Lung Diseases | 2 | 2024 | 61 | 1.110 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2020 | 277 | 1.050 |
Why?
|
| Klebsiella Infections | 2 | 2021 | 7 | 0.970 |
Why?
|
| Klebsiella pneumoniae | 2 | 2021 | 17 | 0.960 |
Why?
|
| Environmental Monitoring | 1 | 2024 | 192 | 0.860 |
Why?
|
| Papillomavirus Infections | 4 | 2020 | 336 | 0.860 |
Why?
|
| Complex Mixtures | 1 | 2021 | 8 | 0.800 |
Why?
|
| Plague | 3 | 2015 | 25 | 0.760 |
Why?
|
| Yersinia pestis | 3 | 2015 | 35 | 0.750 |
Why?
|
| Cervix Uteri | 2 | 2018 | 42 | 0.680 |
Why?
|
| Calcium | 2 | 2021 | 480 | 0.670 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2018 | 15 | 0.650 |
Why?
|
| HMGB1 Protein | 1 | 2018 | 29 | 0.640 |
Why?
|
| HIV-1 | 3 | 2015 | 706 | 0.570 |
Why?
|
| Ethanol | 1 | 2018 | 192 | 0.560 |
Why?
|
| Uterine Cervical Dysplasia | 4 | 2020 | 39 | 0.540 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2015 | 8 | 0.520 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 70 | 0.490 |
Why?
|
| Papillomaviridae | 3 | 2020 | 127 | 0.480 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 2 | 2015 | 19 | 0.480 |
Why?
|
| Mice | 6 | 2024 | 5913 | 0.440 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2024 | 56 | 0.430 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2011 | 259 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 1609 | 0.400 |
Why?
|
| Interferon Type I | 1 | 2011 | 18 | 0.390 |
Why?
|
| Specimen Handling | 3 | 2020 | 56 | 0.380 |
Why?
|
| Thymus Gland | 1 | 2011 | 81 | 0.380 |
Why?
|
| Lung | 3 | 2024 | 446 | 0.370 |
Why?
|
| Cytokines | 3 | 2024 | 602 | 0.340 |
Why?
|
| Vaginal Smears | 2 | 2020 | 57 | 0.340 |
Why?
|
| Inflammation | 3 | 2024 | 618 | 0.330 |
Why?
|
| Animals | 7 | 2024 | 15081 | 0.310 |
Why?
|
| North Carolina | 4 | 2023 | 104 | 0.310 |
Why?
|
| Female | 9 | 2024 | 20969 | 0.260 |
Why?
|
| Air Pollution | 1 | 2024 | 60 | 0.230 |
Why?
|
| Humans | 14 | 2024 | 37093 | 0.230 |
Why?
|
| Vagina | 2 | 2020 | 81 | 0.220 |
Why?
|
| Dendritic Cells | 2 | 2015 | 113 | 0.210 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 220 | 0.210 |
Why?
|
| Internship and Residency | 1 | 2023 | 125 | 0.210 |
Why?
|
| Environmental Exposure | 1 | 2024 | 216 | 0.200 |
Why?
|
| Chemotaxis | 1 | 2021 | 60 | 0.190 |
Why?
|
| Macrophage Activation | 1 | 2021 | 56 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2022 | 208 | 0.190 |
Why?
|
| Zebrafish | 1 | 2022 | 128 | 0.190 |
Why?
|
| Interleukin-6 | 1 | 2021 | 153 | 0.190 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 43 | 0.180 |
Why?
|
| Human papillomavirus 16 | 1 | 2020 | 35 | 0.180 |
Why?
|
| DNA, Viral | 2 | 2020 | 304 | 0.180 |
Why?
|
| Cytoplasm | 1 | 2020 | 143 | 0.180 |
Why?
|
| Interferon-gamma | 1 | 2021 | 250 | 0.180 |
Why?
|
| Urinalysis | 1 | 2020 | 30 | 0.180 |
Why?
|
| Calcium Signaling | 1 | 2020 | 101 | 0.180 |
Why?
|
| Patient Preference | 1 | 2020 | 44 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 356 | 0.170 |
Why?
|
| Male | 3 | 2024 | 20025 | 0.170 |
Why?
|
| HIV Infections | 3 | 2023 | 2303 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 404 | 0.160 |
Why?
|
| Herpesvirus 4, Human | 1 | 2018 | 33 | 0.160 |
Why?
|
| Disease Progression | 2 | 2018 | 601 | 0.160 |
Why?
|
| Cytomegalovirus | 1 | 2018 | 40 | 0.160 |
Why?
|
| Gene Expression | 1 | 2021 | 674 | 0.160 |
Why?
|
| Macrophages | 1 | 2021 | 439 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2024 | 642 | 0.150 |
Why?
|
| Cell Survival | 1 | 2020 | 864 | 0.150 |
Why?
|
| Epithelial Cells | 1 | 2020 | 384 | 0.150 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2018 | 164 | 0.140 |
Why?
|
| Early Detection of Cancer | 4 | 2020 | 336 | 0.140 |
Why?
|
| Aged | 4 | 2020 | 6741 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2021 | 938 | 0.130 |
Why?
|
| Middle Aged | 5 | 2020 | 10129 | 0.130 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 51 | 0.130 |
Why?
|
| United States | 1 | 2024 | 4223 | 0.120 |
Why?
|
| Neutrophil Infiltration | 1 | 2013 | 27 | 0.120 |
Why?
|
| Adult | 5 | 2020 | 11712 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1371 | 0.110 |
Why?
|
| Neutrophils | 1 | 2013 | 131 | 0.110 |
Why?
|
| Flavoring Agents | 2 | 2022 | 20 | 0.100 |
Why?
|
| Cell Line | 2 | 2020 | 1354 | 0.100 |
Why?
|
| Lymphocyte Depletion | 1 | 2011 | 13 | 0.100 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 103 | 0.100 |
Why?
|
| Herpesvirus 8, Human | 1 | 2010 | 25 | 0.090 |
Why?
|
| Colposcopy | 2 | 2020 | 13 | 0.090 |
Why?
|
| Virus Attachment | 1 | 2009 | 3 | 0.090 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2009 | 7 | 0.090 |
Why?
|
| Virus Internalization | 1 | 2009 | 28 | 0.090 |
Why?
|
| Receptors, CXCR4 | 1 | 2009 | 69 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 188 | 0.080 |
Why?
|
| Interferon-alpha | 2 | 2015 | 43 | 0.060 |
Why?
|
| Sensation | 1 | 2022 | 35 | 0.050 |
Why?
|
| Cultural Diversity | 1 | 2023 | 169 | 0.050 |
Why?
|
| Perception | 1 | 2022 | 195 | 0.050 |
Why?
|
| Mentha | 1 | 2020 | 2 | 0.050 |
Why?
|
| Self-Examination | 1 | 2020 | 9 | 0.050 |
Why?
|
| Biopsy | 1 | 2020 | 164 | 0.040 |
Why?
|
| Mycoplasma Infections | 1 | 2018 | 4 | 0.040 |
Why?
|
| Mycoplasma genitalium | 1 | 2018 | 3 | 0.040 |
Why?
|
| Trichomonas Vaginitis | 1 | 2018 | 5 | 0.040 |
Why?
|
| Trichomonas vaginalis | 1 | 2018 | 8 | 0.040 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2018 | 15 | 0.040 |
Why?
|
| Postal Service | 1 | 2018 | 12 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 400 | 0.040 |
Why?
|
| Gonorrhea | 1 | 2018 | 24 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 448 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 562 | 0.040 |
Why?
|
| Chlamydia trachomatis | 1 | 2018 | 68 | 0.040 |
Why?
|
| Genotype | 1 | 2020 | 730 | 0.040 |
Why?
|
| Nicotine | 1 | 2020 | 257 | 0.040 |
Why?
|
| Self Care | 1 | 2018 | 159 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 935 | 0.040 |
Why?
|
| Chlamydia Infections | 1 | 2018 | 196 | 0.030 |
Why?
|
| Biological Warfare Agents | 1 | 2015 | 4 | 0.030 |
Why?
|
| Mass Screening | 1 | 2020 | 462 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 223 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 408 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1398 | 0.030 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2010 | 37 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2010 | 121 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 211 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1518 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2010 | 1908 | 0.010 |
Why?
|